Hikari Tsushin, Inc.
Source: SEC Form 13F · as of Mar 2026Hikari Tsushin, Inc. holds 12 biotech & pharma companies tracked by BioSniper, totaling $84.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$84.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 117,095 | $28.6M |
| ABBVAbbVie Inc. | 104,963 | $22.8M |
| ZTSZoetis Inc. | 188,125 | $22.2M |
| BMYBRISTOL MYERS SQUIBB CO | 81,141 | $4.9M |
| ABTABBOTT LABORATORIES | 32,870 | $3.4M |
| MRKMerck & Co., Inc. | 8,812 | $1.1M |
| NVONovo Nordisk A/S | 23,512 | $864K |
| RPRXRoyalty Pharma plc | 2,220 | $106K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 365 | $99K |
| MOHMolina Healthcare Inc | 687 | $92K |
| AMGNAMGEN INC | 233 | $82K |
| OGNOrganon & Co. | 599 | $4K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.